Regarding the action of MTR and MTRR together in a 1:1 stoichiometric ratio to produce the holoenzyme complex, it seems the variant alleles of MTR and MTRR act in synergy in modulation of BC risk (34). This evidence concerns the gene MTRR and breast cancer.